Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Manuel Felices-Navarro"'
Autor:
Ana M. Espinosa-Oliva, Pablo García-Miranda, Isabel María Alonso-Bellido, Ana E. Carvajal, Melania González-Rodríguez, Alejandro Carrillo-Jiménez, Arturo J. Temblador, Manuel Felices-Navarro, Irene García-Domínguez, María Angustias Roca-Ceballos, María D. Vázquez-Carretero, Juan García-Revilla, Marti Santiago, María J. Peral, José Luis Venero, Rocío M. de Pablos
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Parkinson’s disease is a highly prevalent neurological disorder for which there is currently no cure. Therefore, the knowledge of risk factors as well as the development of new putative molecular targets is mandatory. In this sense, peripheral infl
Externí odkaz:
https://doaj.org/article/d1fc2af0ac2241a0a19c37ad805ef7b5
Autor:
Isabel María Alonso-Bellido, José L. Venero, Marti Santiago, Melania Gonzalez-Rodriguez, Alejandro Carrillo-Jimenez, Juan García-Revilla, Manuel Felices-Navarro, María D. Vázquez-Carretero, Rocío M. de Pablos, María Angustias Roca-Ceballos, Ana E. Carvajal, Irene García-Domínguez, Pablo García-Miranda, Ana M. Espinosa-Oliva, M.J. Peral, Arturo Temblador
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Frontiers in Pharmacology
Digital.CSIC. Repositorio Institucional del CSIC
instname
Frontiers in Pharmacology
Parkinson’s disease is a highly prevalent neurological disorder for which there is currently no cure. Therefore, the knowledge of risk factors as well as the development of new putative molecular targets is mandatory. In this sense, peripheral infl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1ca482d5d8ab8c927ef6b97636d3d61
http://hdl.handle.net/10261/262823
http://hdl.handle.net/10261/262823
